Otros idiomas ChitogenX Inc.

Acciones

CHGX

CA1699161032

Mercado cerrado - Canadian Securities Exchange Otros sitios de cotización 15:49:38 10/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,045 ^CAD	+50,00 %		0,00 %	-30,77 %

27/05	ChitogenX Inc. informa de los resultados del ejercicio finalizado el 31 de enero de 2024	CI
28/02	Chitogenxinc. anuncia la dimisión de Philippe Deschamps del Consejo de Administración	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

ChitogenX : 28 mai 2024 Chitogenx annonce ses rÉsultats pour l’exercice 2024	28/05
CHITOGENX REPORTS 2024 FISCAL YEAR-END RESULTS	28/05
ChitogenX Inc. Reports Earnings Results for the Full Year Ended January 31, 2024	27/05
CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES	28/02
Chitogenxinc. Announces Resignation of Philippe Deschamps from the Board of Directors	28/02
Chitogenx Inc. Announces CEO Changes	28/02
CHITOGENX REPORTS THIRD QUARTER 2024 RESULTS	03/01
ChitogenX Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	02/01
CHITOGENX DEMONSTRATES ORTHO-R EFFICACY AND OSTEOARTHRITIS PROTECTION IN LARGE ANIMAL MENISCAL REPAIR STUDY	09/11
Chitogenx Inc. Demonstrates ORTHO-R Efficacy and Osteoarthritidevelopment in Large Animal Study	09/11
ChitogenX Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23
CHITOGENX REPORTS SECOND QUARTER 2024 RESULTS	29/09/23
ChitogenX Inc. Receives Notice of Allowance for Key Patent in United States and Canada	28/09/23
CHITOGENX RECEIVES NOTICE OF ALLOWANCE FOR KEY PATENT IN UNITED STATES AND CANADA	28/09/23
ChitogenX Concluded Enrolment For Its U.S. Multi-site Rotator Cuff Tear Repair Phase I/II Clinical Trial	26/09/23
ChitogenX : 26 septembre 2023 Chitogenx conclut le recrutement de son Étude clinique amÉricaine de phase i/ii sur la rÉparation des dÉchirures de la coiffe du rotateur	26/09/23
CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL	26/09/23
Chitogenx Concludes Enrolment for Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial	26/09/23
CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS	02/08/23
CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS	03/07/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas ChitogenX Inc.

Acciones

CHGX

CA1699161032

Otros idiomas

Filtros